Fortrea (NASDAQ: FTRE) — Perfil da empresa, notícias e dados financeiros
Fortrea Holdings is a global leader in contract research, assisting companies in drug and device development.
Fortrea
Fortrea Holdings (NASDAQ:FTRE) a global leader in contract research organizations (CROs), assists pharmaceutical, biotechnology, and medical device companies in bringing new treatments and technologies to market. They don't directly offer products or services to consumers, but instead, provide comprehensive solutions throughout the drug and device development process. This includes managing clinical trials, ensuring regulatory compliance, and analyzing data. By supporting the research and development of innovative healthcare solutions, Fortrea plays a crucial role in advancing healthcare and improving patient outcomes.
Resumo
Operações
Produtos e/ou serviços de Fortrea
- Clinical Trial Management: Fortrea manages all aspects of clinical trials, including study design, site selection, patient recruitment, data collection, and regulatory compliance.
- Clinical Pharmacology: They offer services related to the study of how drugs and devices affect the human body, ensuring their safety and efficacy.
- Patient Access Solutions: Fortrea facilitates patient access to clinical trials by removing barriers and ensuring diverse participation across various demographics and geographical regions. This may include patient recruitment strategies, reimbursement assistance, and travel coordination.
- Regulatory Consulting: They provide expert advice and guidance to navigate the complex regulatory landscape of drug and device development, ensuring compliance with all relevant regulations.
- Data Analysis and Reporting: Fortrea analyzes and reports clinical trial data, providing valuable insights to sponsors and regulatory agencies.
- Clinical Trial Project Management & Monitoring: They oversee all aspects of clinical trials, ensuring they are conducted ethically, efficiently, and meet all scientific and regulatory standards.
equipe executiva do Fortrea
- Anshul ThakralCEO & Director
- Mark A. MoraisCOO & President of Clinical Services
- Jill McConnellExecutive Officer
- Drayton VirklerPresident & Chief Commercial Officer
- Jason F. KnoblauchChief Financial Officer
- Carrie RussellVP of Accounting & Chief Accounting Officer
- Alejandro Martinez GalindoChief Information Officer
- Dave CooperChief Administrative Officer
- Tracy H. KrummeSenior VP of Investor Relations
- Agnieszka M. GallagherGeneral Counsel & Corporate Secretary
Últimas notícias sobre a Fortrea
Principais indicadores financeiros
Resultados divulgados pela Fortrea, em USD.
- Cap. de mercado
- 2,5 bi
- Receita (TTM)
- 2,7 bi
- P/L
- —
- LPA (diluído, TTM)
- -1.0
- Dividend yield
- —
- Margem de lucro
- -3.2%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 2,7 bi | -30,6 mi | -986,2 mi | |
| 2,7 bi | -161,9 mi | -328,5 mi | |
| 2,8 bi | 32 mi | -25,2 mi | |
| 2,8 bi | 187,1 mi | 186,2 mi |